BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1356649)

  • 21. Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells.
    Kim R; Ohi Y; Inoue H; Toge T
    Int J Oncol; 1999 Oct; 15(4):751-6. PubMed ID: 10493958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line.
    Murphy L; Henry M; Meleady P; Clynes M; Keenan J
    Biochim Biophys Acta; 2008 Sep; 1784(9):1184-91. PubMed ID: 18503785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A; Bokemeyer C; Scharnofkse M; Hapke G; Reile D; Schmoll HJ
    Cancer Chemother Pharmacol; 1993; 33(1):43-7. PubMed ID: 8269588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
    Sharp SY; Rowlands MG; Jarman M; Kelland LR
    Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
    Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
    Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
    Untch M; Untch A; Sevin BU; Angioli R; Perras JP; Koechli O; Averette HE
    Anticancer Drugs; 1994 Feb; 5(1):24-30. PubMed ID: 7910494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
    Loh SY; Mistry P; Kelland LR; Abel G; Harrap KR
    Br J Cancer; 1992 Dec; 66(6):1109-15. PubMed ID: 1457352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Taxotere: from yew's needles to clinical practice].
    Lavelle F; Gueritte-Voegelein F; Guenard D
    Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
    Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents.
    Vogel M; Hilsenbeck SG; Depenbrock H; Danhauser-Riedl S; Block T; Nekarda H; Fellbaum C; Aapro MS; Bissery MC; Rastetter J
    Eur J Cancer; 1993; 29A(14):2009-14. PubMed ID: 7904173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C; Giocanti N; Favaudon V
    Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD; Shivers RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
    Karantanis E; Nicholson S; Morris DL
    Eur J Surg Oncol; 1994 Dec; 20(6):653-7. PubMed ID: 7995417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A.
    Ciardiello F; Caputo R; Pomatico G; De Laurentiis M; De Placido S; Bianco AR; Tortora G
    Int J Cancer; 2000 Mar; 85(5):710-5. PubMed ID: 10699953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.
    Nomura T; Yamasaki M; Nomura Y; Mimata H
    Oncol Rep; 2005 Oct; 14(4):993-7. PubMed ID: 16142363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.